Pharmaceutical

Listen: SVB’s long biotech shadow, pushy AI algorithms,...

Mar 19, 2023

Is AI dictating patient care? What happens when your bank falls apart? And can I...

STAT+: Here’s why there aren’t many cheap, generic versions of pricey inhalers

STAT+: Here’s why there aren’t many cheap, generic vers...

Mar 19, 2023

“This could make it easier for generic firms to circumvent device patents on inh...

STAT+: Califf criticizes insurers for doing too little on drug research

STAT+: Califf criticizes insurers for doing too little ...

Mar 19, 2023

The FDA chief wants insurers to help with drug research. It’s a new request for ...

U.S. pregnancy deaths dropped in 2022, after Covid spike

U.S. pregnancy deaths dropped in 2022, after Covid spike

Mar 19, 2023

Deaths of pregnant women in the U.S. fell in 2022, dropping significantly from a...

Large network of clinics offering ketamine for depression shuts down

Large network of clinics offering ketamine for depressi...

Mar 19, 2023

One of the largest operators of ketamine clinics in the country abruptly closed ...

STAT+: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge

STAT+: Pharmalittle: Alzheimer’s group starts lobbying ...

Mar 19, 2023

The federal judge who could upend access to an abortion medication pressed gover...

STAT+: U.K. trade group suspends Novo Nordisk for ‘serious breaches’ in promoting obesity drug

STAT+: U.K. trade group suspends Novo Nordisk for ‘seri...

Mar 19, 2023

A U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years ...

STAT+: CRISPR? Nah. A new startup bets on an old approach to gene editing

STAT+: CRISPR? Nah. A new startup bets on an old approa...

Mar 19, 2023

Giving an old genome-editing tool a new twist, Seamless Therapeutics launches ba...

STAT+: Takeda autoimmune therapy shows effectiveness in key trial

STAT+: Takeda autoimmune therapy shows effectiveness in...

Mar 19, 2023

‘We’ll look back and say that this was a bargain.’ Takeda reveals first data fro...